Loading
companiesCompany
Quantum Surgical
Quantum Surgical builds Epione, a robot that helps doctors guide needles through the skin to destroy liver and other tumours with heat or cold, making a minimally invasive treatment more precise and easier for less experienced operators.
Overview
Quantum Surgical, founded in Montpellier in 2017 by Bertin Nahum and the team behind neurosurgical robotics company Medtech, develops the Epione robotic platform for percutaneous tumour ablation. Epione combines CT-based planning, robotic needle positioning and post-ablation margin confirmation to standardise minimally invasive ablation of early-stage tumours that are inoperable or hard to reach. It is CE marked for abdominal, thoracic and musculoskeletal indications and FDA cleared for abdominal ablation; the company reports more than 1,800 patients treated and over 20 cancer centre installations. In February 2026 Quantum Surgical acquired NeuWave Medical, Inc., the microwave ablation company used in about 70 percent of top US cancer centres; both now operate as subsidiaries of the new parent Precision IO Group Inc., led by CEO Kurt Azarbarzin. The same month it joined the EU-funded PreciseOnco consortium (EUR 23.9 million).
Headquarters
Montpellier, FR
Funding
All startupsGrowth stage
Investors not recorded; see the round sources.
Rounds on record
| Round | Year | Amount | Source |
|---|---|---|---|
| Grant · PreciseOnco consortium (with Philips, IGEA, EIBIR and CIRSE) awarded EUR 14.9 million public funding from the EU Innovative Health Initiative plus EUR 9 million in-kind, EUR 23.9 million total; Quantum Surgical's own share is not stated | 2026 | undisclosed | quantumsurgical.com |
Amounts only where the cited source states them. Rounds without a public source are not listed.
Stage
Growth stage
Website
Founded
2017
Notes
top- Venture rounds (Quantum Surgical is known to have raised private capital, including from Ally Bridge Group) could not be sourced from fetched pages; Ally Bridge Group is listed as an investor only because its founder appears on the board page. Stage 'growth' reflects a commercial-stage company now held by a new parent, Precision IO Group; not marked 'acquired' because the parent was created around it. NeuWave deal value not disclosed. Liver, colorectal metastasis and kidney cancers are inferred from ablation indications rather than stated on fetched pages.
Similar pages
- CompanyXACT Robotics
Shares Thermal ablation (RFA, microwave, cryo), CT (computed tomography), Robotic & minimally invasive surgery, Renal cell carcinoma.
- TrialThermal Ablation Combined With Anlotinib and TQB2450 Solution for HCC
Shares Thermal ablation (RFA, microwave, cryo), Hepatocellular carcinoma.
- PersonYuman Fong
Shares Robotic & minimally invasive surgery, Hepatocellular carcinoma, Colorectal cancer.
- CompanyIceCure Medical
Shares Thermal ablation (RFA, microwave, cryo), Renal cell carcinoma.
- TermMicrowave ablation (MWA)
Shares Thermal ablation (RFA, microwave, cryo), Hepatocellular carcinoma, Colorectal cancer.
- CompanyMonteris Medical
Shares Thermal ablation (RFA, microwave, cryo), Robotic & minimally invasive surgery.
- TechnologyPartial nephrectomy, ablation & active surveillance of small renal masses
Shares Thermal ablation (RFA, microwave, cryo), Robotic & minimally invasive surgery, Renal cell carcinoma.
- TermRadiofrequency ablation (RFA)
Shares Thermal ablation (RFA, microwave, cryo), Renal cell carcinoma, Hepatocellular carcinoma, Colorectal cancer.